» Authors » B N Setty

B N Setty

Explore the profile of B N Setty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 410
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Setty B, Chen D, Stuart M
J Lab Clin Med . 1996 Sep; 128(3):313-21. PMID: 8783639
The effects of sickle red cell-endothelial cell interaction on endothelial cell arachidonic: acid (AA) mobilization, eicosanoid release, and diacylglycerol (DAG) production were evaluated by using bovine aortic endothelial cells. We...
12.
Gelman B, Setty B, Chen D, Amin-Hanjani S, Stuart M
Pediatr Res . 1996 Apr; 39(4 Pt 1):692-6. PMID: 8848347
Abnormalities in platelet functions including aggregation and the release reaction have long been recognized to be present in neonatal platelets. Because calcium is an important mediator of many platelet functions,...
13.
Setty B, Chen D, Stuart M
Pediatr Res . 1995 Jul; 38(1):95-102. PMID: 7478805
Plasma levels of 6-keto-prostaglandin F1 alpha (6kPGF1 alpha) and thromboxane (Tx) B2 have been assessed in sickle cell disease (SCD) with discrepant results. Inasmuch as direct measurement of plasma prostanoids...
14.
Setty B, Dampier C, Stuart M
J Lab Clin Med . 1995 May; 125(5):608-17. PMID: 7537788
As an initial investigation into the possible role of endothelial cell (EC) lipoxygenase and cyclooxygenase metabolites in the adherence of red blood cells (RBCs) to ECs, we evaluated the effect...
15.
Dampier C, Setty B, Logan J, Ioli J, Dean R
J Pediatr . 1995 Mar; 126(3):461-7. PMID: 7869211
To examine the pharmacokinetics of parenteral opioids, such as morphine, in patients with sickle cell disease, we determined the plasma morphine clearances in 18 patients (aged 6 to 19 years)...
16.
Setty B, Werner M, Hannun Y, Stuart M
Blood . 1992 Dec; 80(11):2765-73. PMID: 1333301
We investigated whether biologically relevant concentrations of the mono-hydroxyeicosatetraenoic acids (mono-HETEs) modulate platelet functions. We report that 15-HETE, an eicosanoid produced by endothelial cells, granulocytes, and lymphocytes, potentiated platelet aggregation,...
17.
Setty B, Dampier C, Stuart M
Thromb Res . 1992 Sep; 67(5):545-58. PMID: 1448788
1-Deamino-8 D-arginine vasopressin (DDAVP) has been used effectively to normalize the bleeding time in various hemostatic disorders. In von Willebrand disease the reduction in bleeding time is due to the...
18.
Setty B, Phelps D, Walenga R, Stuart M
Exp Eye Res . 1991 Jul; 53(1):81-8. PMID: 1879505
Conversion of arachidonic acid to eicosanoids by kitten retinae was investigated to evaluate whether the pattern of kitten retinal eicosanoids simulates that found in the human and other animal species....
19.
Graeber J, Glaser B, Setty B, Jerdan J, Walenga R, Stuart M
Prostaglandins . 1990 Jun; 39(6):665-73. PMID: 1695384
We evaluated 15-hydroxyeicosatetraenoic acid (15-HETE), a major arachidonic acid product of vascular endothelium and leukocytes, for its effect on neovascularization. In a modified Boyden chamber assay, 15-HETE (10-7 M) stimulated...
20.
Stuart M, Walenga R, Setty B, Phelps D
Biol Neonate . 1990 Jan; 57(5):313-7. PMID: 2322613
The chronic phase of O2-induced retinopathy is characterized by retinal neovascularization. We have previously demonstrated that 15-hydroxy-5,8,11,13-eicosatetraenoic acid (15-HETE), a product of white cells, is proangiogenic. In this study, kittens...